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Despite the presence of large number and diverse popu-
lations of commensal microbes, gut mucosa has evolved
to maintain “microbial-tolerance”, which is critically
regulated by well-controlled Toll-like receptor (TLR)
signaling. Deregulated TLR signaling has been linked to
the pathogenesis of inflammatory bowel disease and
colon cancer; however, the underlying mechanisms need
to be further defined. In this study, we uncovered that
lack of SIGIRR, a negative regulator for TLR and IL-1R
signaling, led to increased genetic instability and LOH
of Apc, resulting in spontaneous colonic polyposis in
Apc
min/+/Sigirr
-/- mice. Importantly, elevated colonic
tumorigenesis in Apc
min/+/Sigirr
-/- mice is dependent on
the presence of commensal microbes in gut, implicating
a critical role for TLR signaling in tumorigenesis.
Furthermore, we demonstrated that SIGIRR-modulated
TLR-mediated tumor initiation is mainly through the
activation of the Akt-mTOR axis, which promotes cell
cycle progression through its impact on posttranscrip-
tional control of the key cell cycle regulators (Cyclins,
c-Myc and cdk2). Moreover, abrogation of mTOR path-
way by rapamycin prevented microadenoma and polyps
formation in Apc
min/+/Sigirr
-/- mice, providing new
insights into treating human cancers. In addition, aug-
mented production of proinflammatory cytokines, such
as IL-6 and IL-23, further promoted tumor growth in
Apc
min/+/Sigirr
-/- mice. Epithelium specific re-expression
of SIGIRR in Apc
min/+/Sigirr
-/- mice ameliorated intest-
inal tumorigenesis. In summary, this study indicates that
SIGIRR is a critical tumor suppressor that controls
tumorigenesis by inhibiting TLR-induced mTOR and
NFkB pathways in colonic epithelium.
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